Eurofins DiscoverX
Biotechnology ResearchCalifornia, United States51-200 Employees
Eurofins DiscoverX functions as the product arm of Eurofins Discovery, supplying tools that support multi-modality drug discovery and development from initial research through QC lot release. Its portfolio includes cell-based assays, ready-to-use kits, stable cell lines, and other assay components that enable work across a range of target families, such as cytokine and checkpoint receptors, GPCRs, kinases, ion channels, epigenetic regulators, and nuclear receptors. The company operates three research and manufacturing centers of excellence in Fremont, California; St. Charles, Missouri; and Poitiers, France. Its customers are drug discovery and development scientists in biotech and pharmaceutical organizations who rely on these tools to advance programs, including potency assessment, target engagement, and quality-control lot release. Based in Fremont, California, Eurofins DiscoverX operates within the biotechnology research industry as a supplier of research tools that enable multi-modality approaches. A recent 2023 update notes work on agonistic antibodies for immunotherapy and autoimmune diseases, reflecting ongoing expansion of its offerings in antibody-related assays.
1-888-653-2347 
support@leadiq.com 
